In a first-ever human clinical trial, an mRNA cancer vaccine developed at the University of Florida successfully reprogrammed patients’ immune systems to fiercely attack glioblastoma, the most aggressive and lethal brain tumor. The results in four adult patients mirrored those in 10 pet dog patients suffering from brain tumors whose owners approved of their participation. […] The post Cancer Vaccine Triggers Fierce Immune Response to Fight Malignant Brain Tumors appeared first on Good News Network.